Literature DB >> 29090501

Prospective, pilot evaluation of the performance of nanofractional radiofrequency for improvement of skin texture via skin resurfacing.

Krista Bohnert1, Andrew Dorizas2, Neil Sadick1,3.   

Abstract

BACKGROUND: The latest generation of radiofrequency, nanofractional radiofrequency, allows the heat energy to be delivered through the use of pins or needles as electrodes, facilitating increased efficacy and reduced pain, downtime, and side effects.
OBJECTIVE: The objective of this prospective pilot clinical study was to evaluate the efficacy of nanofractional radiofrequency in skin resurfacing. METHODS AND MATERIALS: Seventeen subjects were enrolled in the study, and each received three nanofractional radiofrequency (160-pin tip) treatments in the facial area at 3-week intervals. Follow-up visits were scheduled at 1 and 2 months after the final treatment. Clinical photography, patient, and investigator assessments were conducted during the treatment visits and follow-up.
RESULTS: All subjects completed the study. At the 1- and 2-month follow-up, there was a moderate to significant improvement (2.6 and 3.5, respectively, P = .01) according to the investigator global esthetic improvement scale rating. Most subjects reported that they were satisfied or very satisfied with the outcome and level of comfort.
CONCLUSION: Nanofractional radiofrequency is a safe and effective strategy for improving texture, tone, and skin laxity with high patient satisfaction and tolerable safety profile.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  face; nanofractional; radiofrequency; rejuvenation; skin resurfacing

Mesh:

Year:  2017        PMID: 29090501     DOI: 10.1111/jocd.12398

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  1 in total

1.  Subject satisfaction following treatment with nanofractional radiofrequency for the treatment and reduction of acne scarring and rhytids: A prospective study.

Authors:  Suleima Arruda; Alyssa Swearingen; Kathleen Medrano; Neil Sadick
Journal:  J Cosmet Dermatol       Date:  2021-09-24       Impact factor: 2.189

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.